中文摘要：

目的探讨窄谱中波紫外线（NB—UVB）联合郁金银屑片治疗寻常型银屑病的疗效与安全性。方法将人选的96例寻常型银屑病患者随机分为观察组与对照组各48例。对照组予NB—UVB照射治疗，每周3次；观察组在此基础上口服郁金银屑片5片，每日3次。疗程均为8周。观察两组的PASI评分、疗效及不良反应情况。结果治疗4周后．观察组与对照组PASI评分分别为（4．13±2．32）、（6．35±3．14），临床有效率分别为62．5％、39．6％（P〈0．05）。治疗8周后，观察组与对照组PASI评分分别为（2．06±1．20）、（3．58±1．67），临床有效率分别为87．5％、68．8％（P〈0．05）。不同时间点PASI评分进行方差分析显示，差异有统计学意义（P〈0．01）。两组患者不良反应少且轻微。结论NB—UVB联合郁金银屑片治疗寻常型银屑病疗效高，安全性好。

英文摘要：

Objective To investigate the efficacy and safety of yujinyinxie tablet and narrow-band ultraviolet B（NB-UVB） for treatment of psoriasis vulgaris. Methods All of 96 patients with psoriasis vulgaris were randomly divided into observa- tion group and control group with each of 48 cases. The control group were treated with NB-UVB irradiation,3 times/week. On the basis of this, the observation group were treated with yujinyinxie tablets in addition. The course was 8 weeks. PASI score, efficacy and adverse reactions were observed. Results After 4 weeks of treatment, the PASI scores of the observation group and control group were （4.13 ± 2.32） and （6.35 ± 3.14） respectively, and clinical efficacy was 62.5% and 39.6%, respectively （P 〈 0.05）. After 8 weeks of treatment, the PASI scores were （2.06 ±1.20） and （3.58±1.67）, respectively, and clinical efficacy was 87.5% and 68.8%, respectively （P 〈 0.05）. PASI score at different time points were statistically significant by analysis of variance （P 〈 0.01）. The adverse reactions in both two groups were few and mild. Conclusion NB-UVB combined with yujinyinxie tablet is effective and safe in the treatment of psoriasis vulgari.